Related Experiment Video
Updated: Sep 27, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Sickle cell disease
1Children's Hospital and Research Center at Oakland, Department of Hematology/Oncology, 747 52nd Street, Oakland, CA 94609, USA.
Insights
Sickle cell disease is a serious genetic blood disorder affecting African-Americans. This review covers current knowledge on sickle cell disease complications and potential treatments for patients.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Background:
- Sickle cell disease (SCD) is a severe, inherited blood disorder impacting approximately 1 in 600 African Americans.
- First described in 1910, medical understanding and therapeutic strategies for SCD have significantly advanced.
- Pediatricians frequently encounter children with SCD, necessitating comprehensive knowledge of the condition.
Purpose of the Study:
- To provide an updated summary of current knowledge regarding sickle cell disease.
- To detail the known complications associated with sickle cell disease.
- To outline potential treatment options for individuals with sickle cell disease.
Main Methods:
- This article is a review of existing literature on sickle cell disease.
- It synthesizes current understanding of the disease's pathophysiology and clinical manifestations.
- Information on complications and treatments is compiled from established medical resources.
Main Results:
- Sickle cell disease presents with a range of serious complications affecting multiple organ systems.
- Various treatment modalities exist, aimed at managing symptoms and preventing complications.
- Ongoing research continues to explore novel therapeutic approaches for SCD.
Conclusions:
- A thorough understanding of sickle cell disease, its complications, and treatments is crucial for healthcare providers, especially pediatricians.
- Effective management requires a comprehensive approach addressing the multifaceted nature of the disease.
- Continued research and clinical advancements offer hope for improved outcomes in sickle cell disease patients.
Abstract:
Sickle cell disease is a serious and life threatening disease that affects approximately 1 in 600 African-Americans. Since its first description in 1910 by Herrick, our understanding and treatment of this disease has grown tremendously. Most pediatricians will encounter one or more children with sickle cell disease and should have a thorough understanding of the disease, its complications, and treatment. This article summarizes present day knowledge about the complications and potential treatments for patients with sickle cell disease.
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
iPS Cell Differentiation
Translation
Translation
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
